Özlem Türeci and Uğur Şahin (AP Images)

November 17, 2022 05:59 AM ESTUpdated 06:21 AM

Astellas spotlights PFS, OS win for CLDN18.2 — six years after buying BioNTech founders' other company for $1.4B

Amber Tong

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

FDA approves Moderna’s next-gen Covid vaccine, with limits on most healthy people

Summit’s disappointing survival readout raises stakes for full data

Gilead, Merck reveal 'practice-changing' data for Trodelvy-Keytruda combo in aggressive breast cancer

Summit says bispecific misses overall survival in closely-watched lung cancer study

Arvinas, Pfizer's PROTAC in breast cancer no better than oral SERDs

sponsored

From weeks to days: how Aizon Intelligent Agents transform pharma validation